1 / 13

Medical Biochemistry Robert F. Waters, PhD

Medical Biochemistry Robert F. Waters, PhD. Cytochrome P450 System (Introduction). Introduction. Formation of metabolic intermediates Xenobiotics Plants Poisons Toxins Protein sites (Genetic Control) Molecular families Pseudogenes

yuri-lancaster
Download Presentation

Medical Biochemistry Robert F. Waters, PhD

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Medical BiochemistryRobert F. Waters, PhD Cytochrome P450 System (Introduction)

  2. Introduction • Formation of metabolic intermediates • Xenobiotics • Plants • Poisons • Toxins • Protein sites (Genetic Control) • Molecular families • Pseudogenes • Example: 3A4 acetominophen, Lovastatin, codeine, valium, etc. • FMN, Fe, S (NAC), Cu, Zn • Pseudogenes ? • Polymorphisms (Familial)

  3. Cytochrome P450 System • Cytochrome P450 proteins in humans are drug metabolizing enzymes and enzymes that are used to make cholesterol, steroids and other important lipids such as prostacyclins and thromboxane A2. These last two are metabolites of arachidonic acid. (See Next Page) • Induction of some P450s is a risk factor in several cancers since these enzymes can convert procarcinogens to carcinogens. • However….may also be used in cancer. • Cancer patient is given a prodrug (Non-toxic) • Inject a patient with a vector that has CYTP450 gene to convert prodrug to drug • Drug kills cancer cells • Administer reductase to patient to neutralize drug

  4. Acetylsalicylates • Acetylsalicylates • Detoxification (Glucuronic Acid, Glycine) • Attaches to albumen • Note teratogenicity • Inhibits prostaglandin synthesis • Inhibits inflammatory response • Inhibits vasodilation • Inhibits Thromboxane A2 • Inhibits coagulation • Stimulates LT4

  5. Acetominophen Poisoning and GSH • Note: Oxidation (gain oxygen, lose e-, lose H+) • Produces free radicals • Acetaminophen Poisoning • Depletes Erythrocyte and Hepatic GSH • Oxidizes Hb so Fe++ becomes Fe+++ • Called MetHb (Methemoglobinemia) • Cannot bind oxygen • Depletes hepatic glucuronyl transferase • Delayed response!

  6. Diseases Associated with Genetic Lesions • Some diseases associated with Cyt gene mutations: • Congenital glaucoma • Defects in Sodium metabolism(Aldosterone) • Neonatal liver disease • Hypercholesterolemia (Resistant to statin Drugs) • Glucocorticoid deficiencies • Etc.

  7. Cytochrome P450 System • Drug Metabolizing • Cholesterol Production • Steroids • Arachidonic Acid • Vit D., Etc.

  8. Cytochrome P450 Cont: • Production of Carcinogens from Procarcinogens • Excessive detox---be careful! • Oxidases or Monooxygenases • Increase solubility • Cytochrome P450 needs electrons for energy • On the ER the donating protein is NADPH cytochrome P450 reductase • Ferredoxin (adrenodoxin in adrenals) is a donor of electrons in the mitochondria

  9. Cytochrome P450 Cont: • Non-invasive markers for measuring P450 enzymes • Caffeine (For example) • Rate of demethylation • Genetic Profiling (E-sensor)

  10. Genetic Polymorphisms

  11. Cytochrome P450 Cont:

  12. Cytochrome P450 System

  13. FUTURE RESEARCH • Drug-Drug Interactions (Pharmaseutical Companies) • Drug-Botanical Interactions (Not yet begun) • Drug-Food Interactions (Beginning) • Grapefruit juice inhibits Cytp450-3A4 • Botanicals-Foods Interactions (Not yet begun)

More Related